Literature DB >> 25429792

β-Hemolytic streptococcal throat carriage and tonsillopharyngitis: a cross-sectional prevalence study in Gabon, Central Africa.

Sabine Bélard1, Nicole Toepfner, Benjamin Arnold, Abraham Sunday Alabi, Reinhard Berner.   

Abstract

BACKGROUND: Group A streptococcus (GAS) and possibly other β-hemolytic streptococci (BHS) account for a considerable morbidity and mortality burden in African populations; however, disproportionately little is known about the epidemiology of BHS in sub-Saharan Africa. This study assessed the prevalence of GAS, group G streptococcus (GGS) and group C streptococcus (GCS) carriage and tonsillopharyngitis in a Central African population.
METHODS: A prospective cross-sectional study was performed to assess the prevalence of and risk factors for BHS carrier status and tonsillopharyngitis in children and adults in Gabon.
RESULTS: The overall BHS carrier prevalence was 135/1,005 (13.4%); carrier prevalence of GAS, GGS, and GCS was 58/1,005 (5.8%), 50/1,005 (5.0%), and 32/1,005 (3.2%), respectively. Streptococcal carriage was associated with school and pre-school age (adjusted OR 2.65, 95% CI 1.62-4.36, p = 0.0001 and 1.90, 95% CI 1.14-3.17, p = 0.0141, respectively). Participants residing in urban areas were less likely carriers (OR 0.52, p = 0.0001). The point-prevalence of BHS-positive tonsillopharyngitis was 1.0% (9/1,014) and 15.0% (6/40) in school children with sore throat.
CONCLUSIONS: Non-GAS exceeded GAS throat carriage and tonsillopharyngitis suggesting a yet underestimated role of non-GAS streptococci in BHS diseases.

Entities:  

Mesh:

Year:  2014        PMID: 25429792     DOI: 10.1007/s15010-014-0709-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  21 in total

1.  Group A streptococcal carrier versus acute infection: the continuing dilemma.

Authors:  Harry R Hill
Journal:  Clin Infect Dis       Date:  2010-02-15       Impact factor: 9.079

Review 2.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

3.  A clinical score to reduce unnecessary antibiotic use in patients with sore throat.

Authors:  W J McIsaac; D White; D Tannenbaum; D E Low
Journal:  CMAJ       Date:  1998-01-13       Impact factor: 8.262

4.  Burden of disease and barriers to the diagnosis and treatment of group a beta-hemolytic streptococcal pharyngitis for the prevention of rheumatic heart disease in Dar Es Salaam, Tanzania.

Authors:  Regan Bergmark; Brian Bergmark; Jeffrey Blander; Maulidi Fataki; Mohamed Janabi
Journal:  Pediatr Infect Dis J       Date:  2010-12       Impact factor: 2.129

5.  The validity of a sore throat score in family practice.

Authors:  W J McIsaac; V Goel; T To; D E Low
Journal:  CMAJ       Date:  2000-10-03       Impact factor: 8.262

6.  Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.

Authors:  Stanford T Shulman; Alan L Bisno; Herbert W Clegg; Michael A Gerber; Edward L Kaplan; Grace Lee; Judith M Martin; Chris Van Beneden
Journal:  Clin Infect Dis       Date:  2012-11-15       Impact factor: 9.079

7.  Prospective surveillance of streptococcal sore throat in a tropical country.

Authors:  Andrew C Steer; Adam W J Jenney; Joseph Kado; Michael F Good; Michael Batzloff; Graham Magor; Roselyn Ritika; Kim E Mulholland; Jonathan R Carapetis
Journal:  Pediatr Infect Dis J       Date:  2009-06       Impact factor: 2.129

8.  Variation in clinical presentation of childhood group A streptococcal pharyngitis in four countries.

Authors:  Anne W Rimoin; Christa L Fischer Walker; Rohit A Chitale; Hala S Hamza; A Vince; Dace Gardovska; Antonio L da Cunha; S Qazi; Mark C Steinhoff
Journal:  J Trop Pediatr       Date:  2008-03-29       Impact factor: 1.165

9.  Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis.

Authors:  Andrew M Fine; Victor Nizet; Kenneth D Mandl
Journal:  Arch Intern Med       Date:  2012-06-11

10.  Increase in group G streptococcal infections in a community hospital, New York, USA.

Authors:  San S Wong; Yu S Lin; Liby Mathew; Latha Rajagopal; Douglas Sepkowitz
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more
  5 in total

1.  Throat carriage rate, associated factors, and antimicrobial susceptibility pattern of group A Streptococcus among healthy school children in Jigjiga City, Eastern Ethiopia.

Authors:  Shamil Barsenga; Habtamu Mitiku; Tewodros Tesfa; Tadesse Shume
Journal:  BMC Pediatr       Date:  2022-04-26       Impact factor: 2.567

2.  Molecular epidemiology of Staphylococcus aureus from Lambaréné, Gabon.

Authors:  K V Okuda; N Toepfner; A S Alabi; B Arnold; S Bélard; U Falke; L Menschner; S Monecke; A Ruppelt-Lorz; R Berner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-23       Impact factor: 5.103

3.  Asymptomatic carriage of Streptococcus pyogenes among school children in Sana'a city, Yemen.

Authors:  Arwa Mohammed Othman; Rowa Mohammed Assayaghi; Huda Zaid Al-Shami; Riyadh Saif-Ali
Journal:  BMC Res Notes       Date:  2019-06-14

4.  Pharyngeal Carriage of Beta-Haemolytic Streptococcus Species and Seroprevalence of Anti-Streptococcal Antibodies in Children in Bouaké, Côte d'Ivoire.

Authors:  Pacôme Monemo; Nadia Demba; Fidèle S Touré; Adjartou Traoré; Christelle Avi; Micheline A N'Guessan; Juste O Tadet; Arthur R Gobey; Augustin E Anoh; Abdoulaye Diarrassouba; Marie N Tuo; Amadou Cissé; Jasmina Saric; Jürg Utzinger; Honoré Tia; Judith Kouassi-N'Djeundo; Sören L Becker; Chantal Akoua-Koffi
Journal:  Trop Med Infect Dis       Date:  2020-11-27

5.  Impact of intra-partum azithromycin on carriage of group A streptococcus in the Gambia: a posthoc analysis of a double-blind randomized placebo-controlled trial.

Authors:  Isatou Jagne; Alexander J Keeley; Abdoulie Bojang; Bully Camara; Edrissa Jallow; Elina Senghore; Claire Oluwalana; Saikou Y Bah; Claire E Turner; Abdul Karim Sesay; Umberto D'Alessandro; Christian Bottomley; Thushan I de Silva; Anna Roca
Journal:  BMC Infect Dis       Date:  2022-01-29       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.